4//SEC Filing
Lippa Arnold 4
Accession 0001573202-17-000011
CIK 0000849636other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 7:23 PM ET
Size
8.2 KB
Accession
0001573202-17-000011
Insider Transaction Report
Form 4
Lippa Arnold
DirectorChairman, CEO and PresidentOther
Transactions
- Other
Common Stock Options (to purchase shares of Common Stock)
2017-12-09+559,595→ 559,595 totalExercise: $1.45Exp: 2022-12-09→ Commn Stock (559,595 underlying) - Gift
Common Stock Options (to purchase shares of Common Stock)
2017-12-09−559,595→ 0 totalExercise: $1.45Exp: 2022-12-09→ Commmon Stock (559,595 underlying)
Footnotes (2)
- [F1]On December 9, 2017, Dr. Lippa forgave all of the accrued but unpaid compensation to which, pursuant to his employment agreement, he was entitled as of September 30, 2017, an aggregate of $807,497. On that date, the Company granted to Dr. Lippa options to purchase 559,595 shares of the Company's common stock, with a black-scholes value of $1.44 per option and an aggregate value of $807,497. These Common Stock Options vested upon issuance.
- [F2]Dr. Lippa gifted these Common Stock Options into a family trust for estate planning purposes. He is not the trustee and does not exercise voting or investment control over shares held in the trust but he is a beneficiary of the trust.
Documents
Issuer
RespireRx Pharmaceuticals Inc.
CIK 0000849636
Entity typeother
Related Parties
1- filerCIK 0001363763
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 7:23 PM ET
- Size
- 8.2 KB